Cargando…
Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors
The strength of goal-oriented behaviors is regulated by midbrain dopamine neurons. Dysfunctions of dopaminergic circuits are observed in drug addiction and obsessive-compulsive disorder. Compulsive behavior is a feature that both disorders share, which is associated to a heightened dopamine neurotra...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040183/ https://www.ncbi.nlm.nih.gov/pubmed/32132923 http://dx.doi.org/10.3389/fphar.2020.00057 |
_version_ | 1783500929933246464 |
---|---|
author | Escobar, Angélica del Pilar Casanova, José Patricio Andrés, María Estela Fuentealba, José Antonio |
author_facet | Escobar, Angélica del Pilar Casanova, José Patricio Andrés, María Estela Fuentealba, José Antonio |
author_sort | Escobar, Angélica del Pilar |
collection | PubMed |
description | The strength of goal-oriented behaviors is regulated by midbrain dopamine neurons. Dysfunctions of dopaminergic circuits are observed in drug addiction and obsessive-compulsive disorder. Compulsive behavior is a feature that both disorders share, which is associated to a heightened dopamine neurotransmission. The activity of midbrain dopamine neurons is principally regulated by the homeostatic action of dopamine through D2 receptors (D2R) that decrease the firing of neurons as well as dopamine synthesis and release. Dopamine transmission is also regulated by heterologous neurotransmitter systems such as the kappa opioid system, among others. Much of our current knowledge of the kappa opioid system and its influence on dopamine transmission comes from preclinical animal models of brain diseases. In 1988, using cerebral microdialysis, it was shown that the acute activation of the Kappa Opioid Receptors (KOR) decreases synaptic levels of dopamine in the striatum. This inhibitory effect of KOR opposes to the facilitating influence of drugs of abuse on dopamine release, leading to the proposition of the use of KOR agonists as pharmacological therapy for compulsive drug intake. Surprisingly, 30 years later, KOR antagonists are instead proposed to treat drug addiction. What may have happened during these years that generated this drastic change of paradigm? The collected evidence suggested that the effect of KOR on synaptic dopamine levels is complex, depending on the frequency of KOR activation and timing with other incoming stimuli to dopamine neurons, as well as sex and species differences. Conversely to its acute effect, chronic KOR activation seems to facilitate dopamine neurotransmission and dopamine-mediated behaviors. The opposing actions exerted by acute versus chronic KOR activation have been associated with an initial aversive and a delayed rewarding effect, during the exposure to drugs of abuse. Compulsive behaviors induced by repeated activation of D2R are also potentiated by the sustained co-activation of KOR, which correlates with decreased synaptic levels of dopamine and sensitized D2R. Thus, the time-dependent activation of KOR impacts directly on dopamine levels affecting the tuning of motivated behaviors. This review analyzes the contribution of the kappa opioid system to the dopaminergic correlates of compulsive behaviors. |
format | Online Article Text |
id | pubmed-7040183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70401832020-03-04 Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors Escobar, Angélica del Pilar Casanova, José Patricio Andrés, María Estela Fuentealba, José Antonio Front Pharmacol Pharmacology The strength of goal-oriented behaviors is regulated by midbrain dopamine neurons. Dysfunctions of dopaminergic circuits are observed in drug addiction and obsessive-compulsive disorder. Compulsive behavior is a feature that both disorders share, which is associated to a heightened dopamine neurotransmission. The activity of midbrain dopamine neurons is principally regulated by the homeostatic action of dopamine through D2 receptors (D2R) that decrease the firing of neurons as well as dopamine synthesis and release. Dopamine transmission is also regulated by heterologous neurotransmitter systems such as the kappa opioid system, among others. Much of our current knowledge of the kappa opioid system and its influence on dopamine transmission comes from preclinical animal models of brain diseases. In 1988, using cerebral microdialysis, it was shown that the acute activation of the Kappa Opioid Receptors (KOR) decreases synaptic levels of dopamine in the striatum. This inhibitory effect of KOR opposes to the facilitating influence of drugs of abuse on dopamine release, leading to the proposition of the use of KOR agonists as pharmacological therapy for compulsive drug intake. Surprisingly, 30 years later, KOR antagonists are instead proposed to treat drug addiction. What may have happened during these years that generated this drastic change of paradigm? The collected evidence suggested that the effect of KOR on synaptic dopamine levels is complex, depending on the frequency of KOR activation and timing with other incoming stimuli to dopamine neurons, as well as sex and species differences. Conversely to its acute effect, chronic KOR activation seems to facilitate dopamine neurotransmission and dopamine-mediated behaviors. The opposing actions exerted by acute versus chronic KOR activation have been associated with an initial aversive and a delayed rewarding effect, during the exposure to drugs of abuse. Compulsive behaviors induced by repeated activation of D2R are also potentiated by the sustained co-activation of KOR, which correlates with decreased synaptic levels of dopamine and sensitized D2R. Thus, the time-dependent activation of KOR impacts directly on dopamine levels affecting the tuning of motivated behaviors. This review analyzes the contribution of the kappa opioid system to the dopaminergic correlates of compulsive behaviors. Frontiers Media S.A. 2020-02-18 /pmc/articles/PMC7040183/ /pubmed/32132923 http://dx.doi.org/10.3389/fphar.2020.00057 Text en Copyright © 2020 Escobar, Casanova, Andrés and Fuentealba http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Escobar, Angélica del Pilar Casanova, José Patricio Andrés, María Estela Fuentealba, José Antonio Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors |
title | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors |
title_full | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors |
title_fullStr | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors |
title_full_unstemmed | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors |
title_short | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors |
title_sort | crosstalk between kappa opioid and dopamine systems in compulsive behaviors |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040183/ https://www.ncbi.nlm.nih.gov/pubmed/32132923 http://dx.doi.org/10.3389/fphar.2020.00057 |
work_keys_str_mv | AT escobarangelicadelpilar crosstalkbetweenkappaopioidanddopaminesystemsincompulsivebehaviors AT casanovajosepatricio crosstalkbetweenkappaopioidanddopaminesystemsincompulsivebehaviors AT andresmariaestela crosstalkbetweenkappaopioidanddopaminesystemsincompulsivebehaviors AT fuentealbajoseantonio crosstalkbetweenkappaopioidanddopaminesystemsincompulsivebehaviors |